Production of motif-specific and context-independent antibodies using peptide libraries as antigens

• US 7,259,022 B2
• Filed: 11/13/2001
• Issued: 08/21/2007
• Est. Priority Date: 09/04/1998
• Status: Expired due to Fees

• Current Assignee: Cell Signaling Technology Incorporated
• Original Assignee: Cell Signaling Technology Incorporated
• Inventors: Comb, Michael J., Zhang, Hui, Tan, Yi
• Primary Examiner(s): Canella; Karen A.
• Application Number:
  US10/014,485
• Publication Number:
  US 20020168684A1
• Time in Patent Office: 2,107 Days
• Field of Search: 435/69.1, 435/70.1, 435/70.21, 530/387.1, 530/388.1, 530/389.1
• US Class Current: 436/547
• CPC Class Codes: C07K 16/00 Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies antibodies with enzymatic activity, e.g. abzymes C12N9/0002
• CPC Class Codes: C07K 16/44 against material not provided for elsewhere , e.g. haptens, metals, DNA, RNA, amino acids

Abstract

A method is provided for producing motif-specific, context-independent antibodies which recognize a plurality of peptides or proteins within a genome that contain the same motif. The method includes the step of immunizing a host with a degenerate peptide library antigen featuring (i) a fixed target motif containing one or more invariant amino acids including at least one modified amino acid, and (ii) a plurality of degenerate amino adds flanking the motif. Motif-specific, context-independent antibodies produced by the disclosed method are also provided. The method encompasses motifs consisting of a single modified amino acid, as well as short motifs comprising multiple invariant amino acids including one or more modified amino acids, such as all or part of kinase consensus substrate motifs, protein-protein binding motifs, or other cell signaling motifs. Methods of using the antibodies, e.g. for genome-wide profiling, are also provided.

Claims

1. A method for producing a motif-specific, context-independent antibody that specifically binds a recurring, modified motif in a plurality of peptides or proteins within an organism in which it recurs, said method comprising the steps of:

(a) constructing a degenerate peptide library comprising (i) a fixed target motif comprising two to six invariant amino acids including at least one modified amino acid, and, optionally, one or more degenerate amino acid position(s), and (ii) a plurality of degenerate amino acids flanking said motif;

(b) immunizing a host with said peptide library to raise a context-independent antibody specific for all or part of said target motif; and

(c) isolating antisera from said host, and purifying the motif-specific, context-independent antibody of step (b) from said antisera, said antibody specifically binding said motif in a plurality of peptides or proteins within an organism in which it recurs.

2. The method of claim 1, further comprising the step of utilizing spleen cells from the host of step (b) to generate at least one monoclonal, motif-specific, context-independent antibody.

3. The method of claim 1, wherein said modified amino acid is selected from the group consisting of a phosphorylated amino acid, an acetylated amino acid, and a methylated amino acid, and a nitrosylated amino acid.

4. The method of claim 1, wherein said target motif comprises all or part of a kinase consensus substrate motif.

5. The method of claim 4, wherein said kinase consensus substrate motif is selected from the group consisting of a MAPK consensus substrate motif, a CDK consensus substrate motif, a PKA consensus substrate motif, an Akt consensus substrate motif, a PKC consensus substrate motif, and an ATM consensus substrate motif.

6. The method of claim 4, wherein said kinase consensus substrate motif is selected from the group consisting of a PKC Zeta consensus substrate motif, an ABL kinase consensus substrate motif, a CDK5 consensus substrate motif, an insulin receptor consensus substrate motif, a CaMKII consensus substrate motif, a Src kinase consensus substrate motif, a CDC2/CDK2 consensus substrate motif, and a GSK3 kinase consensus substrate motif.

7. The method of claim 1, wherein said target motif is phosphothreonine-X-(R/K) or proline-phosphoserine-proline.

8. The method of claim 1, wherein said peptide library is from 6 to 20 amino acids long.

9. The method of claim 1, wherein said peptide library is from 6 to 14 amino acids long.

10. A motif-specific, context-independent antibody that specifically binds a recurring, phosphorylated motif consisting of (i) two to six invariant amino acids including at least one phosphorylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), said antibody specifically binding said motif in a plurality of non-homologous peptides or proteins within an organism in which it recurs.

11. The antibody of claim 10, wherein said motif is a kinase consensus substrate motif or a protein-protein binding motif.

12. The antibody of claim 11, wherein said kinase consensus substrate motif is selected from the group consisting of a MAPK consensus substrate motif, a CDK consensus substrate motif, a PKA consensus substrate motif, an AKT consensus substrate motif;

a PKC consensus substrate motif, and an ATM consensus substrate motif.

13. The antibody of claim 11, wherein said kinase substrate motif is selected from the group consisting of a PKC Zeta consensus substrate motif, an ABL kinase consensus substrate motif, a CDK5 consensus substrate motif, an insulin receptor consensus substrate motif, a CaMKII consensus substrate motif, a Src kinase consensus substrate motif, a CDC2/CDK2 consensus substrate motif, and a GSK3 kinase consensus substrate motif.

14. The antibody of claim 10, wherein said motif is phosphothreonine-X-(R/K) or proline-phosphoserine-proline.